Instil Bio, Inc.
TIL
$11.49
$0.716.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.26% | -32.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.45% | -10.91% | |||
| Operating Income | -16.45% | 10.91% | |||
| Income Before Tax | 36.49% | 24.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 36.49% | 24.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 36.49% | 24.13% | |||
| EBIT | -16.45% | 10.91% | |||
| EBITDA | -16.46% | 7.82% | |||
| EPS Basic | 38.00% | 24.87% | |||
| Normalized Basic EPS | -22.20% | 11.31% | |||
| EPS Diluted | 38.00% | 24.87% | |||
| Normalized Diluted EPS | -22.20% | 11.31% | |||
| Average Basic Shares Outstanding | 2.44% | 0.98% | |||
| Average Diluted Shares Outstanding | 2.44% | 0.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||